Global Live Cell Imaging Market Estimated to reach USD 9.0 billion by 2025

 Global Live Cell Imaging Market is estimated to reach USD 9.0 billion by 2025 owing to the increasing popularity of kinetic research over fixed cellular analysis. Live cell imaging is the study of cells in real-time with the help of images obtained from microscopes and screening systems. Technology has enhanced the approach of scientists to examine proteins, internal cell structures molecular synergy and cellular processes. This allows them to observe cells and to understand the in-depth analysis instead of learning the images of fixed cells.


More information that is precise can be achieved with the help of live cell imaging that plays an important role in understanding cell dynamics in research fields like immunology, microbiology, neurology and others. Technological modernizations in live cell imaging are projected to fulfill the demands of different end-users. Technological improvements along with other factors are likely to boost the live cell imaging market in the forecast period at CAGR of 8.5%.


The growing concern of cancer is one of the major factors for the rising demand for the live cell imaging technology. Moreover, governments worldwide are taking initiatives to fund the cell-based research which will contribute live cell imaging industry. Besides, live cell imaging can be used for a wide number of applications along with understanding of dynamics processes of cellular structures.


Request a Sample Copy of This Report: https://www.millioninsights.com/industry-reports/live-cell-imaging-market/request-sample


Additionally, live cell imaging can also be used to study cell integrity, enzyme activity, protein trafficking exocytosis, localization of molecules and endocytosis among others. Likewise, the process can also be applied to observe the molecules in live animals. The pharmaceuticals companies are also adopting the live cell imaging for high-quality screening. Conversely, the costly installation of live cell imaging is acting as a restraint for the live cell imaging industry. Dearth in technical proficiency also restrains the market growth. Moreover, with rising investments in training and developments programs is expected to affect comparatively less in the near future. Also, the live cell imaging techniques is gradually being used in the pharmaceutical companies to develop personalized medicine which is predicted to fuel the market.


Live cell imaging market is categorized on the basis of product type, technology, application and geography. On the basis of product type, the market is divided into Consumable, Equipment, and Software. Equipment is projected to hold larger share of live cell imaging industry in near future. The equipment segmented is further divided into microscopes, cell analyzers, standalone systems, and image-capturing instruments. Based on consumables, the market is divided into assay kits, media, reagents and others.


In terms of technology, live cell imaging market is segmented into fluorescence in situ hybridization (FISH), fluorescence resonance energy transfer (FRET), fluorescence recovery after photobleaching (FRAP), high-content analysis (HCA), ratiometric imaging, total internal reflection fluorescence microscopy (TRIF), multiphoton excitation microscopy (MPE), and others. On the basis of application, is divided into Stem cells, Cell Biology and Drug Discovery.


Browse Full Research Report with TOC:  https://www.millioninsights.com/industry-reports/live-cell-imaging-market


Geographically, the market is segmented as North America, Europe, Asia Pacific, Latin America and Middle East & Africa. North America is predicted to hold larger share of the market followed by Asia Pacific and Europe. The prominent live cell imaging industry players comprise Becton, Carl Zeiss AG, Leica Microsystems, Molecular Devices, LCC, PerkinElmer, Inc., Nikon Corporation, GE Healthcare, Dickinson and Company, Thermo Fisher Scientific, Inc., Olympus Corporation, and Sigma-Aldrich Corporation.


Market Segment:


Live Cell Imaging Product Outlook (Revenue, USD Million, 2014 - 2025)

    • Equipment

    • Consumable

    • Software


Live Cell Imaging Application Outlook (Revenue, USD Million, 2014 - 2025)

    • Cell Biology

    • Developmental Biology

    • Stem Cell & Drug Discovery

    • Others


Live Cell Imaging Technology Outlook (Revenue, USD Million, 2014 - 2025)

    • Time lapse Microscopy

    • Fluorescence recovery after photobleaching (FRAP)

    • Fluorescence resonance energy transfer (FRET)

    • High content screening (HCS)

    • Others


Live Cell Imaging Regional Outlook (Revenue, USD Million, 2014 - 2025)

    • North America

        • U.S.

        • Canada

    • Europe

        • UK

        • Germany

    • Asia Pacific

        • China

        • Japan

    • Latin America

        • Brazil

        • Mexico

    • MEA

        • South Africa

continue........


Get In Touch

At Million Insights, we work with the aim to reach the highest levels of customer satisfaction. Our representatives strive to understand diverse client requirements and cater to the same with the most innovative and functional solutions.


Contact Person: 

Ryan Manuel

Research Support Specialist, USA

Email: ryan@millioninsights.com


Global Headquarters

Million Insights

Felton Office Plaza 6265 Highway 9 Felton, California 95018, United States

Phone: 1-408-610-2300

Email: sales@millioninsights.com


Asia Pacific

Million Insights

Office No. 302, 3rd Floor, Manikchand Galleria, Model Colony, Shivaji Nagar, Pune, MH, 411016 India

Phone: 91-20-65300184


Comments

Post a Comment

Popular posts from this blog

Global and Chinese Bufexamac Market Outlook and Analysis 2019 to 2022

15-mar-2019 The Bufexamac Market 2017 Report offers detailed analysis of the Bufexamac market over the last five years, and provides extensive market forecasts by region/country and sub sector. It covers the key technological and market trends in the Bufexamac market. It further lays out an analysis of the factors influencing the supply/demand for Bufexamac, and the opportunities/challenges faced by industry participants. It also acts as an essential tool to companies active across the value chain and to the new entrants by enabling them to capitalize the opportunities and develop business strategies. In particular, it provides an in-depth analysis of the following: Market overview: detailed analysis of the whole value chain (upstream & downstream), insights into technological developments, and an extensive analysis of costs analysis from the aspects of raw materials, labor costs and etc. Market size and driving factors: comprehensive analysis of the global Bufexamac market...
Read more

Global Diabetes Care Products Market Study 2016-2022

14-mar-2019 In this report, the global Diabetes Care Products market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Diabetes Care Products for these regions, from 2012 to 2022 (forecast), covering United States China Europe Japan Southeast Asia India Global Diabetes Care Products market competition by top manufacturers/players, with Diabetes Care Products sales volume, Price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including BD Bayer Abbott B. Braun Medtronic Tandem Diabetes Care Insulet Corporation Roche J&J ARKRAY Inc Ypsomed Sannuo Sanofi On the basis of product, this report displays the production, revenue, price, market share and growth rate of each ...
Read more

Antidiabetic Biguanides Market Survey - Global Industry Share, Size, Trends and Forecasts, 2017

This report studies sales (consumption) of Antidiabetic Biguanides in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering • Anderson Hay & Grain Inc. • Border Valley • Sanofi • Takeda Pharmaceuticals • Eli Lilly • Merck & Co. • Novo Nordisk Request a Sample Copy of This Report:  https://www.radiantinsights.com/research/global-antidiabetic-biguanides-sales-market-report-2017/request-sample Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Antidiabetic Biguanides in these regions, from 2011 to 2021 (forecast), like • United States • China • Europe • Japan • Southeast Asia • India Split by product Types, with sales, revenue, price and gross margin, market share and growth rat...
Read more